Current Cancer Therapy Reviews

Editor-in-Chief:

Kurt S. Zaenker
Institute of Immunology and Experimental Oncology
Witten/Herdecke University
Stockumerstraße 10, 58448 Witten
Germany

Back

Become EABM
Become Reviewer

Recent Advances in Combined Modality Treatment for Locally Advanced Pancreatic Cancer

Volume:1   Issue: 3
Pp: 227-237
Gorkem Aksu, Binnaz Sarper, Cuneyt Ulutin and Hakan Bakkal
DOI: 10.2174/157339405774574199

Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia

Volume:1   Issue: 3
Pp: 239-250
Bulent Ozpolat, Maribel Tirado-Gomez and Gabriel Lopez-Berestein
DOI: 10.2174/157339405774574180

Antioxidant Supplements, Genetics and Chemotherapy Outcomes

Volume:1   Issue: 3
Pp: 251-258
Christine B. Ambrosone, Jiyoung Ahn and Vreni Schoenenberger
DOI: 10.2174/157339405774574252

IP6 & Inositol in Cancer Prevention and Therapy

Volume:1   Issue: 3
Pp: 259-269
Abul K.M. Shamsuddin and Ivana Vucenik
DOI: 10.2174/157339405774574216

Inhibitors of the Hedgehog Signal Transduction Pathway

Volume:1   Issue: 3
Pp: 277-288
David J. Robbins, John A. Goetz, Ziqiang Yuan and Melanie A. Stegman
DOI: 10.2174/157339405774574243

Experimental Onco-Immunology Revisited

Volume:1   Issue: 3
Pp: 289-298
Christiane D. Pasqualini, Raul A. Ruggiero, Oscar D. Bustuoabad, Irene Nepomnaschy and Isabel Piazzon
DOI: 10.2174/157339405774574225